Christopher Miller
13Patents
4h-index
37Co-inventors
60Inventor score
Filing activity: Jan 29, 1998 → May 2, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6326392A | Anti-estrogen plus progestin containing oral contraceptives | Human Necessities | 29 | Expired |
| US7576215B2 | Quinolines and pharmaceutical compositions thereof | Chemistry; Metallurgy | 14 | Expired |
| US6589980B2 | Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents | Chemistry; Metallurgy | 11 | Expired |
| US6455568B2 | Combination therapy for inhibiting sphincter incontinence | Human Necessities | 6 | Expired |
| US6774248B2 | Substituted 2-phenyl benzofurans as estrogenic agents | Chemistry; Metallurgy | 4 | Expired |
| US11952349B2 | Anti-cancer nuclear hormone receptor-targeting compounds | Chemistry; Metallurgy | 2 | Active |
| US12006314B2 | Anti-cancer nuclear hormone receptor-targeting compounds | Chemistry; Metallurgy | 2 | Active |
| US6559177B2 | 5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as estrogenic agents | Chemistry; Metallurgy | 1 | Expired |
| US5939435A | 2-substituted-1-acyl-1,2-dihydroquinoline derivatives | Chemistry; Metallurgy | 1 | Expired |
| US7022733B2 | Substituted 2-phenyl benzofurans as estrogenic agents | Chemistry; Metallurgy | 0 | Expired |
| US7592363B2 | Indazoles | Chemistry; Metallurgy | 0 | Expired |
| US7235539B2 | 6-Hydroxyequilenins as estrogenic agents | Human Necessities | 0 | Expired |
| US11834458B2 | Anti-cancer nuclear hormone receptor-targeting compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.